Published in J Cell Biol on November 01, 1984
Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. Proc Natl Acad Sci U S A (1986) 2.10
Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J Cell Biol (1985) 2.05
Proteoglycans in health and disease: structures and functions. Biochem J (1986) 1.75
A unique heparan sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells. J Cell Biol (1986) 1.58
The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc Natl Acad Sci U S A (1991) 1.51
Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J Cell Biol (1987) 1.48
Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J Cell Biol (1989) 1.15
Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. Proc Natl Acad Sci U S A (1989) 1.10
Heparin regulates the collagen phenotype of vascular smooth muscle cells: induced synthesis of an Mr 60,000 collagen. J Cell Biol (1985) 1.08
Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. J Cell Biol (1988) 1.07
Effect of heparin on synthesis of short chain collagen by chondrocytes and smooth muscle cells. J Cell Biol (1987) 0.83
Modulation of mesangial cell migration by extracellular matrix components. Inhibition by heparinlike glycosaminoglycans. Am J Pathol (1988) 0.79
Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells. Mol Biol Cell (1997) 0.78
Inhibition of phosphatidylinositol 4-phosphate kinase by heparin. A possible mechanism for the antiproliferative effects of heparin. Biochem J (1992) 0.78
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem (1974) 113.22
How does the extracellular matrix direct gene expression? J Theor Biol (1982) 6.38
Capillary endothelial cell cultures: phenotypic modulation by matrix components. J Cell Biol (1983) 3.60
Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J Cell Biol (1981) 3.41
Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature (1977) 3.25
Modulation of secreted proteins of mouse mammary epithelial cells by the collagenous substrata. J Cell Biol (1984) 3.16
Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies. Circ Res (1980) 2.40
Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase. J Biol Chem (1982) 1.99
Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol (1984) 1.71
Role of fibronectin as a growth factor for fibroblasts. J Cell Biol (1983) 1.64
What controls smooth muscle phenotype? Atherosclerosis (1982) 1.57
Purification and properties of human platelet heparitinase. J Biol Chem (1982) 1.42
The extracellular matrix and the control of proliferation of vascular endothelial and vascular smooth muscle cells. J Supramol Struct (1980) 1.08
Structurally distinct collagen types. Annu Rev Biochem (1980) 6.43
The elastic fiber. I. The separation and partial characterization of its macromolecular components. J Cell Biol (1969) 4.51
The nature of the intramolecular cross-links in collagen. The separation and characterization of peptides from the cross-link region of rat skin collagen. Biochemistry (1966) 4.04
Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol (1998) 3.27
Evidence for procollagen, a biosynthetic precursors of collagen. Proc Natl Acad Sci U S A (1971) 2.96
Correlation of procollagen mRNA levels in normal and transformed chick embryo fibroblasts with different rates of procollagen synthesis. Biochemistry (1978) 2.85
Cleavage at Asn-Gly bonds with hydroxylamine. Methods Enzymol (1977) 2.80
Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc Natl Acad Sci U S A (1988) 2.73
The biosynthesis of collagen. Annu Rev Biochem (1974) 2.50
Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. J Biol Chem (1991) 2.47
Role of basic fibroblast growth factor in vascular lesion formation. Circ Res (1991) 2.38
Thrombospondin: synthesis and secretion by cells in culture. J Cell Biol (1982) 2.33
Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture. Apparent identity with platelet thrombospondin. J Biol Chem (1981) 2.25
Light microscopic immunolocation of thrombospondin in human tissues. J Histochem Cytochem (1985) 2.20
Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2. J Biol Chem (2000) 2.18
Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. Proc Natl Acad Sci U S A (1986) 2.10
Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev Dyn (1997) 2.05
Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J Cell Biol (1985) 2.05
Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture. J Biol Chem (1984) 2.01
Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci U S A (1999) 2.01
Cell surface-associated structural proteins in connective tissue cells. Proc Natl Acad Sci U S A (1977) 1.99
Phosphotyrosyl-protein phosphatase. Specific inhibition by Zn. J Biol Chem (1981) 1.95
Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci U S A (1991) 1.94
Effects of antimicrotubular agents on the secretion of collagen. A biochemical and morphological study. J Cell Biol (1974) 1.93
Differential expression of thrombospondin 1, 2, and 3 during murine development. Dev Dyn (1993) 1.92
Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2. Mol Biol Cell (2000) 1.85
Interactions of thrombospondin with extracellular matrix proteins: selective binding to type V collagen. J Cell Biol (1984) 1.85
Isolation of a collagen-binding fragment from fibronectin and cold-insoluble globulin. J Biol Chem (1979) 1.80
Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene. J Invest Dermatol (1999) 1.79
Characterization of the pro- 1 chain of procollagen. J Biol Chem (1972) 1.78
Structural studies on human type IV collagen. J Biol Chem (1979) 1.77
Isolation and characterization of the cyanogen bromide peptides from the alpha-1 chain of rat skin collagen. Biochemistry (1967) 1.77
Regulation of collagen gene expression. Prog Nucleic Acid Res Mol Biol (1989) 1.75
Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest (1990) 1.73
The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism. J Biol Chem (2001) 1.72
Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol (1984) 1.71
Coordinate transcriptional regulation of type I procollagen genes by Rous sarcoma virus. J Biol Chem (1981) 1.68
X-linked cutis laxa: defective cross-link formation in collagen due to decreased lysyl oxidase activity. N Engl J Med (1980) 1.62
Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. J Biol Chem (1987) 1.62
The nature and location of intramolecular cross-links in collagen. Proc Natl Acad Sci U S A (1966) 1.60
Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. J Histochem Cytochem (1993) 1.56
Sulfated proteoglycans synthesized by vascular endothelial cells in culture. J Biol Chem (1983) 1.55
The amino acid sequence of peptides from the cross-linking region of rat skin collagen. Biochemistry (1967) 1.54
Microtubules in transcellular movement of procollagen. Nat New Biol (1972) 1.53
Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism. EMBO J (2001) 1.51
Secretory phenotypes of endothelial cells in culture: comparison of aortic, venous, capillary, and corneal endothelium. Arteriosclerosis (1982) 1.49
Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J Cell Biol (1987) 1.48
TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mitochondrial receptor for the proapoptotic protein Bax. Cell Death Differ (2006) 1.47
Altered secretion of type III procollagen in a form of type IV Ehlers-Danlos syndrome. Biochemical studies in cultured fibroblasts. Lab Invest (1981) 1.46
Comparative sequence studies of rat skin and tendon collagen. I. Evidence for incomplete hydroxylation of individual prolyl residues in the normal proteins. Biochemistry (1967) 1.46
Altered extracellular matrix remodeling and angiogenesis in sponge granulomas of thrombospondin 2-null mice. Am J Pathol (2001) 1.45
Novel embryonic genes are preferentially expressed by autonomously replicating rat embryonic and neointimal smooth muscle cells. Circ Res (2000) 1.45
Synthesis of types I and III procollagen and collagen by monkey aortic smooth muscle cells in vitro. Biochemistry (1977) 1.44
Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity. Proc Natl Acad Sci U S A (1999) 1.42
Biochemical and ultrastructural studies of proteoheparan sulfates synthesized by PYS-2, a basement membrane-producing cell line. J Cell Biol (1982) 1.41
Collagen synthesis by bovine aortic endothelial cells in culture. Biochemistry (1979) 1.40
Epidermal growth factor stimulates the phosphorylation of synthetic tyrosine-containing peptides by A431 cell membranes. Proc Natl Acad Sci U S A (1982) 1.39
Structure of alpha-1-CB8, a large cyanogen bromide produced fragment from the alpha-1 chain of rat collagen. The nature of a hydroxylamine-sensitive bond and composition of tryptic peptides. Biochemistry (1970) 1.39
An upstream regulatory region mediates high-level, tissue-specific expression of the human alpha 1(I) collagen gene in transgenic mice. Mol Cell Biol (1991) 1.36
A presumptive subunit of elastic fiber microfibrils secreted by arterial smooth-muscle cells in culture. Eur J Biochem (1976) 1.36
The distribution of antigenic determinants in rat skin collagen. J Exp Med (1971) 1.35
Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking thrombospondin 2. J Bone Miner Res (2000) 1.35
Isolation and characterization of the cyanogen bromide peptides from the alpha 1 and alpha 2 chains of human skin collagen. Biochemistry (1970) 1.34
NH2-terminal sequence of the chick proalpha1(I) chain synthesized in the reticulocyte lysate system. Evidence for a transient hydrophobic leader sequence. J Biol Chem (1979) 1.34
Transforming growth factor and epidermal growth factor stimulate the phosphorylation of a synthetic, tyrosine-containing peptide in a similar manner. J Biol Chem (1982) 1.34
Biosynthetic and structural properties of endothelial cell type VIII collagen. J Biol Chem (1983) 1.34
Metaxin is a component of a preprotein import complex in the outer membrane of the mammalian mitochondrion. J Biol Chem (1997) 1.32
Changes in surface properties of normal and transformed cells caused by tunicamycin, an inhibitor of protein glycosylation. Proc Natl Acad Sci U S A (1977) 1.32
Regulation of thrombospondin secretion by cells in culture. J Cell Physiol (1984) 1.32
Location of a collagen-binding domain in fibronectin. J Biol Chem (1980) 1.31
Quantitative export of FGF-2 occurs through an alternative, energy-dependent, non-ER/Golgi pathway. J Cell Physiol (1995) 1.30
Cell-specific expression of alpha 1(I) collagen-hGH minigenes in transgenic mice. J Cell Biol (1994) 1.28
Characterization of a novel collagen chain in human placenta and its relation to AB collagen. Biochemistry (1979) 1.28
The distribution of the matricellular protein thrombospondin 2 in tissues of embryonic and adult mice. J Histochem Cytochem (1998) 1.27
Structural basis for apparent heterogeneity of collagens in human basement membranes: type IV procollagen contains two distinct chains. Proc Natl Acad Sci U S A (1980) 1.25
Impaired conversion of procollagen to collagen by fibroblasts and bone treated with tunicamycin, an inhibitor of protein glycosylation. J Biol Chem (1977) 1.24
A unique, pepsin-sensitive collagen synthesized by aortic endothelial cells in culture. Biochemistry (1980) 1.23
Expression of thrombospondins by endothelial cells. Injury is correlated with TSP-1. Am J Pathol (1995) 1.23
Characterization of a type IV procollagen synthesized by human amniotic fluid cells in culture. J Biol Chem (1979) 1.23
Studies of morphologically atypical ("sprouting") cultures of bovine aortic endothelial cells. Growth characteristics and connective tissue protein synthesis. J Cell Physiol (1980) 1.21
Structure of rat skin collagen 1-CB8. Amino acid sequence of the hydroxylamine-produced fragment HA1. Biochemistry (1971) 1.21
Structural analysis and expression of the human thrombospondin gene promoter. J Biol Chem (1988) 1.21
Procollagen: conversion of the precursor to collagen by a neutral protease. Science (1972) 1.20
Characterization of the precursor form of type VI collagen. J Biol Chem (1984) 1.20
Declining procollagen mRNA sequences in chick embryo fibroblasts infected with rous sarcoma virus. Correlation with procollagen synthesis. J Biol Chem (1979) 1.18
Metaxin 1 interacts with metaxin 2, a novel related protein associated with the mammalian mitochondrial outer membrane. J Cell Biochem (1999) 1.18
The specific nonenzymatic cleavage of bovine ribonuclease with hydroxylamine. J Biol Chem (1970) 1.17
Structure and organization of the human metaxin gene (MTX) and pseudogene. Genomics (1996) 1.16
Vascular smooth muscle cells express distinct transforming growth factor-beta receptor phenotypes as a function of cell density in culture. J Biol Chem (1989) 1.15
Interchain disulfide bonds in procollagen are located in a large nontriple-helical COOH-terminal domain. Proc Natl Acad Sci U S A (1975) 1.14
The cross-linking of collagen and elastin and its inhibition in osteolathyrism. Is there a relation to the aging process? Am J Med (1970) 1.13
A serum response element and a binding site for NF-Y mediate the serum response of the human thrombospondin 1 gene. J Biol Chem (1993) 1.13
Amniotic fluid fibronectin. Characterization and synthesis by cells in culture. J Cell Biol (1978) 1.12
Thrombospondin 3 (Thbs3), a new member of the thrombospondin gene family. J Biol Chem (1992) 1.12
Tyrosylprotein kinase and phosphatase activities in membrane vesicles from normal and Rous sarcoma virus-transformed rat cells. Proc Natl Acad Sci U S A (1981) 1.11
Regulation of protein synthesis: translational control by procollagen-derived fragments. Proc Natl Acad Sci U S A (1981) 1.11
Regulation of expression of the type I collagen genes. Am J Med Genet (1993) 1.10
Biosynthesis of an unusual collagen type by human astrocytoma cells in vitro. J Biol Chem (1983) 1.10